ReviewCancer medicine2019

Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment.

Antonino Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.